focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWAND.L Regulatory News (WAND)

  • There is currently no data for WAND

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Board Update

23 Feb 2017 07:00

RNS Number : 6400X
WANdisco Plc
23 February 2017
 

23 February 2017

WANdisco plc

("WANdisco" or the "Company")

 

Board update

 

WANdisco (LSE: WAND), the world leader in Active Data Replication™ today announces the following board changes.

 

Dr Yeturu Aahlad, 58, who is part of the core team that founded WANdisco in 2005, is appointed to the board with immediate effect. Dr Aahlad is a pioneer in the field of active-active data replication, a patented process that sits at the heart of WANdisco's core technology, WANdisco Fusion. Dr Aahlad has a Ph.D in the field of Distributed Computing from the University of Texas, Austin and a BS in Electronics and Communication from IIT Madras.

 

In addition, the Company announces that James (Jim) Campigli, Chief Operating Officer, Head of Marketing, Co-Founder and member of the board will be stepping down with immediate effect to pursue other business interests. He leaves with the board's thanks for the significant contribution he has made since WANdisco's inception.

 

David Richards, Chief Executive Officer and Interim Chairman of WANdisco, commented:

 

"We are delighted to welcome Dr Aahlad to the board. As a founder and pioneer of WANdisco's patented technology, he is a natural addition and we believe he offers a wealth of industry experience which will be invaluable as we implement our near term growth strategy. I would also like to thank Jim for his tremendous contribution in the development of WANdisco and wish him well in all his future endeavours."

 

Dr Aahlad currently has a beneficial holding of 2,825,021 Ordinary Shares in the Company representing 7.62% of the Company's issued share capital.

 

There are no further disclosures required relating to Dr Aahlad's appointment in accordance with Schedule 2(g) of the AIM Rules.

 

For further information, please contact:

 

WANdisco plc

via Vigo Communications

David Richards, Chief Executive Officer and Interim Chairman

 

Erik Miller, Chief Financial Officer

 

Vigo Communications

+44 (0)207 830 9707

Jeremy Garcia / Fiona Henson / Antonia Pollock

www.vigocomms.com

Stifel (Joint Broker and Nomad)

+44 (0)207 710 7600

Fred Walsh / Neil Shah / Ben Maddison / Rajpal Padam

 

 

 

UBS (Joint Broker)

Rahul Luthra / Sandip Dhillon

+44 (0)207 567 8000

 

About WANdisco

 

WANdisco (LSE: WAND) is the world leader in Active Data Replication™. Its patented technology provides continuous consistent access to changing data anytime and anywhere with no downtime and no disruption. WANdisco's patented technology serves crucial high availability (HA) requirements, including migration to cloud, Hadoop Big Data and Application Lifecycle Management (ALM), Subversion, Git and Gerrit. 

 

WANdisco works directly with Fortune 1000 companies around the world and in all sectors to ensure their data, whether it is on-premise or in the cloud, gives them the real insight they need. WANdisco has an OEM with IBM and is also partnered with Amazon Web Services, Cisco, Google Cloud Platform, Hewlett Packard Enterprise, Microsoft Azure and Oracle to resell its patented technology. WANdisco is committed to the ODPi Interoperable Compliance Program to ensure its products are interoperable across a wider range of commercial Apache™ Hadoop® Platforms.

 

For additional information, please visit www.wandisco.com.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOALIFFRFSIVFID
Date   Source Headline
27th Feb 20197:00 amRNSHolding(s) in Company
20th Feb 20192:42 pmRNSHolding(s) in Company
15th Feb 20193:11 pmRNSHolding(s) in Company
14th Feb 20197:00 amRNSAdvanced Technology Partner status with AWS
14th Feb 20197:00 amRNSSubscription for shares raising $17.5m
1st Feb 20197:00 amRNSTotal Voting Rights
10th Jan 20199:02 amRNSTotal Voting Rights
9th Jan 20194:35 pmRNSPrice Monitoring Extension
8th Jan 20197:00 amRNSSQL product launch with IBM
3rd Jan 20197:00 amRNSInaugural Multi-Cloud Contract Win
27th Dec 20187:00 amRNSHealthcare Contract Win
13th Dec 20187:00 amRNSSignificant health insurance contract win
10th Dec 20187:00 amRNSDirector Dealings and Issue of Equity
3rd Dec 20187:00 amRNSBlock admission notification
3rd Dec 20187:00 amRNSTotal Voting Rights
19th Nov 20187:00 amRNSHire of SVP of marketing
19th Nov 20187:00 amRNSBoard change
7th Nov 201810:29 amRNSTotal Voting Rights
5th Nov 20187:00 amRNSContract win
31st Oct 20187:00 amRNSDirector Dealings
24th Oct 201811:11 amRNSDirector Dealings and Issue of Equity
17th Oct 20187:00 amRNSWANdisco launches LiveData for Multicloud
16th Oct 20189:32 amRNSDirector Dealings and Issue of Equity
12th Oct 20187:00 amRNSDirector/PDMR Shareholding
3rd Oct 20185:34 pmRNSDirector Dealings and Issue of Equity
2nd Oct 20188:27 amRNSTotal Voting Rights
25th Sep 20187:01 amRNSAutomotive contract win
25th Sep 20187:00 amRNSHalf-year Report
3rd Sep 20187:30 amRNSTotal Voting Rights
3rd Sep 20187:00 amRNSWANdisco plc Trading Update
1st Aug 20187:00 amRNSWANdisco's Total Voting Rights
25th Jul 20187:00 amRNSNew blockchain patent filing and VP of Engineering
3rd Jul 20189:00 amRNSWANdisco Total Voting Rights
29th May 20184:55 pmRNSBlock Listing Six Monthly Return
23rd May 201811:27 amRNSResult of AGM
22nd May 201812:05 pmRNSHolding(s) in Company
2nd May 20186:19 pmRNSTotal Voting Rights
25th Apr 20182:54 pmRNSHolding(s) in Company
16th Apr 20184:02 pmRNSHolding(s) in Company
4th Apr 20183:11 pmRNSHolding(s) in Company
3rd Apr 20184:56 pmRNSTotal Voting Rights
27th Mar 20181:44 pmRNSHolding(s) in Company
14th Mar 20187:00 amRNSDirector/PDMR Dealing
12th Mar 20187:00 amRNSWANdisco announces Co-Sell status with Microsoft
7th Mar 20187:00 amRNSAppointment of Joint Corporate Broker
7th Mar 20187:00 amRNSOEM SALES PARTNERSHIP WITH ALIBABA CLOUD
7th Mar 20187:00 amRNSPreliminary Results
2nd Mar 20187:18 amRNSTotal Voting Rights
26th Feb 201810:02 amRNSNotice of Results
1st Feb 20185:07 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.